CGTBiologicstaleImmunityBio, Inc.Phase 2
PSA-based Oncolytic Virus (ETBX-071, ETBX-071 (PSA-based Oncolytic Virus))
High-risk Prostate Cancer · High-risk Prostate Cancer
#High-riskProstateCancer#CGT#Phase2#세포유전치료#CAR-T+2
효능 ORR 0%임상시험 3상태 DISCONTINUED